Samarra Drug Company starts first domestic Moxifloxacin Antibiotic output
Source ↗
👁 0
💬 0
Baghdad (IraqiNews.com) — The State Company for Drug Industries and Medical Appliances in Samarra (SDI), an affiliate of the Iraqi Ministry of Industry and Minerals, announced on Monday, August 24, 2026, the successful domestic production of Moxifloxacin, a broad-spectrum fluoroquinolone antibiotic targeting five distinct bacterial infections, marking its first addition to the company’s manufacturing portfolio.
In an official statement received by IraqiNews.com, SDI Director General, Ch
In an official statement received by IraqiNews.com, SDI Director General, Ch
Comments (0)